Position in INCY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$951,176
-$234,854 QoQ
Shares Held
10,106
-15.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MIZUHO SECURITIES USA LLC holds $14,821,803 across 7 Biotechnology names. INCY ranks #4 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,355 | $6,856,621 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,094 | $4,708,468 | |
| 3 | MRNA |
Moderna, Inc.
|
21,023 | $1,067,968 | |
| 4 | INCY |
Incyte Corp
This page
|
10,106 | $951,176 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
11,083 | $584,295 | |
| 6 | TECH |
BIO-TECHNE Corp
|
9,458 | $494,275 | |
| 7 | VSTM |
Verastem, Inc.
|
30,000 | $159,000 |
All Filings in INCY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $951,176 | 10,106 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,186,030 | 12,008 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,013,225 | 11,947 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $755,705 | 11,097 | Shares | Defined | 2025-08-01 | |
| No filing history on record for this holder in this stock. | ||||||